Publication | Open Access

Efficacy and safety of once-daily single-inhaler triple therapy (FF/UMEC/VI) versus FF/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trial

AsthmaPulmonary CareAllergyVersus Ff/viClinical TrialsPulmonary MedicineMedicinePulmonary Disease